Phase 2 Study Targeting Specific Genes in Pediatric Solid Tumors

Share this content:
The NCI and COG announced open enrollment for a study designed to evaluate the effectiveness of genetically matched targeted therapies for pediatric patients with cancer.
The NCI and COG announced open enrollment for a study designed to evaluate the effectiveness of genetically matched targeted therapies for pediatric patients with cancer.

The National Cancer Institute (NCI) and Children's Oncology Group (COG) announced open enrollment for a study designed to evaluate the effectiveness of genetically matched targeted therapies for pediatric patients with cancer.1

NCI-COG Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) is a phase 2 trial that will assess 8 different drugs targeting specific sets of genetic mutations in solid tumors no longer responsive to standard therapy or progressive after therapy.

Tumor types include histiocytoses, brain tumors, and non-Hodgkin lymphomas.

To enroll in the study, a sample of the patient's relapsed tumor must undergo DNA and RNA sequencing. Once matched, patients will continue to receive the study drug as long as the tumor is stable in size or shrinks.

Study researchers estimate that around 1000 patients will need to be screened to find eligible candidates for the study; the mutations being investigated are found in only about 10% of tumors from children and adolescents with cancer.

RELATED: Ipilimumab Indication Expanded To Include Pediatric Unresectable or Metastatic Melanoma

The study will open initially with 6 treatment arms, and may expand to 8 or more. Each study arm will enroll at least 20 patients.

Reference

  1. NCI-COG pediatric MATCH trial to test targeted drugs in childhood cancers [news release]. Bethesda, MD: National Cancer Institute; July 24, 2017. https://www.cancer.gov/news-events/press-releases/2017/nci-pediatric-match-trial-opens?cid=eb_govdel. Accessed July 26, 2017.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters